Circulating malignant lymphocytes from Sezary syndrome express high level of glycoproteins carrying beta (1-6)N-acetylglucosamine-branched N-linked oligosaccharides

Leukemia. 1996 Jan;10(1):138-41.

Abstract

The circulating forms of malignant cells from patients with Sezary syndrome exhibit on their glycoproteins a high level of beta (1-6)GlcNAc-branched N-linked oligosaccharides, a particular species of glycans related to the metastatic potential of several tumors and T lymphocytes activation. An increased activity of the N-acetylglucosaminyltransferase V and of the beta (1-4)galactosyltransferase, two enzymes implicated in beta (1-6)GlcNAc-branching is also found. Nevertheless, contrary to activated normal T lymphocytes, Sezary lymphocytes in agreement with their non-proliferating state, do not exhibit increased thymidine uptake. This result suggests that expression of the beta (1-6)GlcNAc-branched N-linked carbohydrates could be related to some of the malignant properties of Sezary lymphocytes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylglucosamine / blood*
  • Female
  • Glycoproteins / blood*
  • Glycoproteins / chemistry
  • Humans
  • Lymphocyte Activation
  • Lymphocytes / metabolism*
  • Lymphocytes / pathology
  • Male
  • Middle Aged
  • N-Acetylglucosaminyltransferases / metabolism
  • Oligosaccharides / blood*
  • Sezary Syndrome / blood*
  • Sezary Syndrome / enzymology
  • Sezary Syndrome / immunology
  • Skin Neoplasms / blood*
  • Skin Neoplasms / enzymology
  • Skin Neoplasms / immunology
  • T-Lymphocytes / immunology
  • beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase / metabolism

Substances

  • Glycoproteins
  • Oligosaccharides
  • N-Acetylglucosaminyltransferases
  • alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferase
  • beta-N-Acetylglucosaminylglycopeptide beta-1,4-Galactosyltransferase
  • Acetylglucosamine